Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case report
- PMID: 22156787
- DOI: 10.1177/0883073811425423
Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case report
Abstract
Spinal muscular atrophy is a relatively stable chronic disease. Patients may gradually experience declines in muscle strength and motor function over time. However, functional progression is difficult to document, and the mechanism remains poorly understood. An 11-year-old girl was diagnosed at 19 months and took a few steps without assistance at 25 months. She was evaluated for 54 months in a prospective multicenter natural history study. Outcome measures were performed serially. From 6 to 7.5 years, motor function improved. From 7.5 to 11 years, motor function declined with increasing growth. Manual muscle testing scores minimally decreased. Motor unit number estimation studies gradually increased over 4.5 years. Compared to the published natural history of spinal muscular atrophy type III, our patient lost motor function over time. However, she walked with assistance 2 years longer than expected. Our report highlights possible precipitating factors that could affect the natural history of spinal muscular atrophy type III.
Similar articles
-
The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.Neuromuscul Disord. 2006 Jun;16(6):374-80. doi: 10.1016/j.nmd.2006.03.005. Epub 2006 May 2. Neuromuscul Disord. 2006. PMID: 16632361
-
Spinal muscular atrophy: survival pattern and functional status.Pediatrics. 2004 Nov;114(5):e548-53. doi: 10.1542/peds.2004-0668. Epub 2004 Oct 18. Pediatrics. 2004. PMID: 15492357
-
Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study.Neuromuscul Disord. 2012 Dec;22(12):1069-74. doi: 10.1016/j.nmd.2012.06.352. Epub 2012 Nov 3. Neuromuscul Disord. 2012. PMID: 23127961
-
Clinical outcome measures in spinal muscular atrophy.J Child Neurol. 2009 Aug;24(8):968-78. doi: 10.1177/0883073809332702. Epub 2009 Jun 9. J Child Neurol. 2009. PMID: 19509409 Review.
-
Functional and surgical treatments in patients with spinal muscular atrophy (SMA).Arch Pediatr. 2020 Dec;27(7S):7S35-7S39. doi: 10.1016/S0929-693X(20)30275-X. Arch Pediatr. 2020. PMID: 33357596 Review.
Cited by
-
Case Report: Atypical motor development in a patient with the mosaic form of Down syndrome and spinal muscular atrophy type 2- long-term observation.Front Genet. 2024 Nov 22;15:1483903. doi: 10.3389/fgene.2024.1483903. eCollection 2024. Front Genet. 2024. PMID: 39649095 Free PMC article.
-
Newborn screening for spinal muscular atrophy: The views of affected families and adults.Am J Med Genet A. 2017 Jun;173(6):1546-1561. doi: 10.1002/ajmg.a.38220. Epub 2017 Apr 4. Am J Med Genet A. 2017. PMID: 28374951 Free PMC article.
-
Emerging therapies and challenges in spinal muscular atrophy.Ann Neurol. 2017 Mar;81(3):355-368. doi: 10.1002/ana.24864. Epub 2017 Feb 17. Ann Neurol. 2017. PMID: 28026041 Free PMC article. Review.
-
The Genetics of Spinal Muscular Atrophy: Progress and Challenges.Neurotherapeutics. 2015 Apr;12(2):290-302. doi: 10.1007/s13311-014-0314-x. Neurotherapeutics. 2015. PMID: 25413156 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources